ACTU
Actuate Therapeutics, Inc.
$1.33
-0.19 (-12.50%)
At close · Jul 8
Market Cap
$29.43M
Shares
23,925,852
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$22.23M
+18.5%
FY2025
Diluted EPS
-$1.06
+67.5%
FY2025
Operating Cash Flow
-$19.21M
+12.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $9.64M | $10.29M | $18.68M | $21.71M | |
| $12.2M | $12.2M | $6.48M | $3.27M | |
| $21.84M | $22.5M | $25.16M | $24.97M | |
| -$21.84M | -$22.5M | -$25.16M | -$24.97M | |
| $20.25K | $20.25K | $18.72K | $43.64K | |
| $319.36K | $287.71K | $222.29K | $352.67K | |
| $299.11K | $267.46K | -$2.12M | $229.21K | |
| — | $800 | $800 | $0 | |
| -$21.54M | -$22.23M | -$27.29M | -$24.74M | |
| USD/shares | — | -$1.06 | -$3.26 | -$17.24 |
| USD/shares | — | -$1.06 | -$3.26 | -$17.24 |
| shares | — | 21.02M | 8.37M | 1.43M |
| shares | — | 21.02M | 8.37M | 1.43M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.